 VALENCIA, Calif. and MELBOURNE, Australia, Oct. 25, 2021 GLOBE NEWSWIRE -- AVITA Medical, Inc. NASDAQ: RCEL, ASX: AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today it plans to release its fiscal first quarter 2022 financial results after the market closes on Monday, November 8, 2021. In conjunction with such release, the Company plans to host a conference call and webcast on November 8 at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time being 8:30 a.m. Australian Eastern Daylight Time on Tuesday, November 9 to discuss its financial results and recent highlights. 